VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,065,000 | +18.1% | 45,839 | +5.5% | 0.07% | -13.1% |
| Q4 2017 | $902,000 | +691.2% | 43,455 | +449.2% | 0.08% | +546.2% |
| Q4 2016 | $114,000 | -94.5% | 7,912 | -90.0% | 0.01% | -96.1% |
| Q1 2016 | $2,070,000 | -30.0% | 78,727 | +374.7% | 0.33% | -35.9% |
| Q3 2015 | $2,958,000 | +260.3% | 16,583 | +301.0% | 0.52% | +154.2% |
| Q1 2015 | $821,000 | +16.6% | 4,135 | -31.1% | 0.20% | -41.0% |
| Q4 2013 | $704,000 | +7.2% | 6,000 | -4.8% | 0.34% | -15.5% |
| Q3 2013 | $657,000 | – | 6,300 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |